Functional Nanorealgar Quantum Dots with Aggregation-Induced Emission Enhancement for Tumor Neovascular-Targeted Theranostics

Figure 6

(a) Body weight changes; (b) tumor growth rates; (c) photographic images of mice during the treatment of saline and NR@RGD QDs for 16 days (n = 6); (d) blood routine and liver/kidney function indicators of mice; (e) the expression of VEGFA protein in tumor tissues by using WB analysis. β-Actin served as loading control. The partial electrophoretic gel imaging has been circled for comparison displayed in red.

(a)

(b)

(c)

(d)

(e)